Who to follow: HealthTech executives
SL
Sungwon Lim, PhD
Co-Founder and CEO · ImpriMed
Pharma & Life SciencesNorth AmericaEstablished
Why follow Sungwon
Builds precision-oncology systems combining live patient-derived cancer-cell assays with multimodal data and AI-supported treatment insights.
Writes about
Precision OncologyFunctional TestingMultimodal AI
Best for
Precision medicine and oncology builders